Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

News & Blog

Catch the latest

Recent Announcements & Press

October 11, 2021

Octave Bioscience Announces Strategic Investment from Merck Global Health Innovation Fund

July 13, 2021

Personalized Approach to Measuring and Managing MS and Other Neurodegenerative Diseases with Bill Hagstrom Octave Bioscience

March 17, 2021

Octave Welcomes Maital Shemesh-Rasmussen as Chief Commercial Officer

Octave Note

Media Library